Primary Research

 
Fund Quotes for Primary Research top ^
  • Holdings: Intel Corp , Pfizer Inc , Royal Dutch Shell PLC ADR Class A , Eli Lilly and Co , Cisco Systems Inc ,
  • Category: Large Value
  • Morningstar Rating: 2 Stars
Sign-up for ptfdx investment picks
  • Holdings: Samsung Electronics Co Ltd , Roche Holding AG Dividend Right Cert. , Bayer AG , Sanofi , ING Groep N.V. ,
  • Category: Foreign Large Value
  • Morningstar Rating: 4 Stars
Sign-up for tfeqx investment picks
  • Category: Money Market-Taxable
Sign-up for fvusa001u9 investment picks
  • Category: Money Market-Taxable
Sign-up for us3139165043 investment picks
  • Holdings: Samsung Electronics Co Ltd , Roche Holding AG Dividend Right Cert. , Bayer AG , Sanofi , ING Groep N.V. ,
  • Category: Foreign Large Value
  • Morningstar Rating: 4 Stars
Sign-up for us8802105051 investment picks

 
News Articles for Primary Research top ^
2014/12/11
OAK BROOK, Il , Dec.
Sign-up for Primary Energy Recycling Obtains Court Approval for Arrangement investment picks
2014/12/17
OAK BROOK, Il , Dec.
Sign-up for Fortistar led consortium completes acquisition of Primary Energy Recycling Corporation investment picks
2014/12/9
OAK BROOK, IL , Dec.
Sign-up for Primary Energy Recycling Obtains Shareholder Approval for Arrangement investment picks
2014/12/30
NEW YORK , Dec.
Sign-up for New Survey: Only 2% Of Consumers Use Mobile As Primary Method Of Banking investment picks
2015/2/9
Alcoa (NYSE:AA) announced today that Nahla A.
Sign-up for Nahla Azmy Joins Alcoa as Vice President, Investor Relations; Alcoa Appoints Kelly Pasterick Vice President, Global Financial Processes, Global Primary Products investment picks
2014/12/3
RAMSEY, N.J., Dec.
Sign-up for ADMA Biologics Announces Positive Top-Line Phase III Data for Primary Immune Deficiency Disease (PIDD) Patients investment picks
2014/12/4
The LuViva® Advanced Cervical Scan continues to demonstrate the capability to screen the general population for cervical cancer and to eliminate unnecessary testing for women who are screened by other methods, according to recent studies presented at the 25 th Turkish Society of Gynecology Oncology Congress.
Sign-up for Clinical Results Presented at Turkish Medical Congress Further Support LuViva® Advanced Cervical Scan for Primary Screening and Detection of Cervical Cancer investment picks
2015/1/5
Cerus Corporation (NASDAQ:CERS) announced today that its European Phase 3 clinical trial of red blood cells treated with the INTERCEPT Blood System for acute anemia in cardiovascular surgery patients met the primary endpoint.
Sign-up for Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint investment picks
2014/12/22
Cerus Corporation (NASDAQ:CERS) announced today that its Phase 2 clinical trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated red blood cells continued to circulate 24 hours following transfusion.
Sign-up for Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint investment picks
2014/12/17
Barclays Bank PLC announced today the transfer of primary listing venue for 10 iPath® Exchange Traded Notes (the “ETNs”) to the NASDAQ Stock Market.
Sign-up for Barclays Announces the Transfer of Primary Listing for Ten iPath® Exchange Traded Notes investment picks
2015/1/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168338&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for CORRECTION - Star Bulk Carriers Corp. Announces Upsizing & Pricing of Primary Public Offering of 49,000,418 Common Shares investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Primary Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Primary Energy Recycling  |  Next: Prime Rate